首頁 > 市場調查報告書 > 醫療設備

泌尿科

市場調查報告書

商品編碼

1617058

腎臟病學和泌尿系統市場報告：至2030年的趨勢、預測和競爭分析

Nephrology and Urology Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年12月02日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腎臟病學和泌尿系統的趨勢和預測

全球腎臟病學和泌尿系統市場的未來看起來充滿希望，醫院、診所和門診手術中心市場充滿機會。預計到2030年，全球腎臟病和泌尿系統市場將達到 97億美元，2024年至2030年年複合成長率為 6.6%。該市場的主要促進因素是慢性病盛行率的上升、透析患者數量的增加以及對微創（MI）設備的日益偏好。

在產品類型中，Lucintel預測經皮腎造口導管將在預測期內大量使用，因為經皮腎造口導管主要用於治療腎移植問題、腎臟或腎週儲存減壓以及非擴張性閉塞治療。
在最終用途類別中，由於腎臟病患者住院人數的增加、先進治療設備的隨時可用以及在醫療機構接受透析的患者的增加，醫院可能仍然是最大的部分。
從地區來看，由於腎臟病患者數量不斷增加、熟練醫生的存在以及成熟的醫療設施的存在，預計北美在預測期內將出現最高的成長。

腎臟科和泌尿系統市場的策略性成長機會

各種應用和其他因素創造了該領域的策略成長機會。

擴大遠端醫療：擴大遠距遠端醫療服務是重要途徑，不僅可以加強病患管理，還可以改善獲得照護的機會。必須開發強大的遠端醫療平台，以縮小服務不足人口的服務差距。
機器人手術系統：成為機器人手術系統的投資者提供了成長的機會，因為它提供了尖端的手術解決方案。在臨床環境中，它提高了泌尿系統手術的準確性和結果。
人工腎臟技術的進步為透析市場帶來了成長機會。這意味著目的是使慢性腎臟病管理更加有效和方便的創新可以解決這一未滿足的需求。
個人化治療解決方案：在腎臟病學和泌尿系統領域，這種利用患者資料的個人化醫療方法具有推動成長的潛力。因此，這些進展預計將改善治療結果和患者滿意度。
診斷工具的創新：透過增加可用診斷工具的種類可以改善腎臟和泌尿系統疾病的早期檢測和監測。因此，診斷成像和生物標記測試的進步將提高診斷準確性。

此類機會透過推動創新和改善患者照護來塑造腎臟病學和泌尿系統市場。

腎臟病學和泌尿系統市場的促進因素和挑戰

腎臟病和泌尿系統市場受到各種促進因素的影響，這也是影響其成長和市場發展的主要挑戰。

腎臟科和泌尿系統市場的促進因素包括：

技術進步：創新診斷工具、手術技術和數位健康解決方案的使用將推動該細分市場的成長。這些改進將提高腎科護理的整體效率和有效性，特別是對於泌尿系統而言。
腎臟和泌尿系統疾病的發生率不斷增加：腎臟和泌尿系統疾病的盛行率不斷增加，導致需要更複雜的治療方案。這一趨勢推動新技術和治療方法的開發和傳播。
更加關注個人化醫療：向個人化醫療的轉變透過根據患者個體情況量身定做醫療方案來改善治療結果。這種方法不僅在泌尿系統而且在腎臟病學中得到認可。
遠端醫療服務的擴展：遠端醫療服務的成長日益增加獲得治療的機會並改善病患管理。腎臟內科、泌尿系統的治療開始採用遠距會診和監護。
增加研發投資：這筆資金將透過研發投資促進腎臟科和泌尿系統技術的進步。特別支援新治療方法和診斷工具的開發。

腎臟病學和泌尿系統市場面臨的挑戰如下：

先進技術的高成本：先進技術設備的高成本可能成為其採用的障礙。醫療保健提供者和患者面臨著平衡成本和可近性的挑戰。
監管和合規問題：在確保滿足標準的同時就一系列監管要求進行談判可能會出現問題。它影響市場准入和新產品批准等問題。
資料隱私問題：確保病患資料的安全和隱私是一項重大挑戰。遵守資料保護規則和滿足患者需求對於維持信任非常重要。

腎臟病學和泌尿系統市場是由這些影響創新、採購決策和監管要求的促進因素和挑戰所塑造的。

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
全球腎臟病學和泌尿系統市場趨勢（2018-2023）和預測（2024-2030）
全球腎臟病學和泌尿系統市場：依產品
- 輸尿管導管
- PCN導管
- 輸尿管支架
- 取石網
- 泌尿系統導管導引線
- 腎擴張器
- 其他
全球腎臟病學和泌尿系統市場：依應用分類
- 尿道結石
- 泌尿系統癌症及良性前列腺增生
- 膀胱疾病
- 腎臟疾病
- 其他
全球腎病學和泌尿系統市場：依最終用途行業
- 醫院
- 診所
- 門診手術中心
- 其他

第4章 2018-2030年市場趨勢及預測分析，依地區

依地區分類的全球腎臟病學和泌尿系統市場
北美腎臟病學/泌尿系統市場
歐洲腎臟病學和泌尿系統市場
亞太腎臟病學和泌尿系統市場
其他地區腎臟病、泌尿系統市場

第5章競爭分析

產品系列分析
業務整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球腎臟病學和泌尿系統市場成長機會，依產品
- 全球腎臟病學和泌尿系統市場成長機會，依應用
- 全球腎臟病學和泌尿系統市場成長機會，依最終用途產業
- 全球腎臟病學和泌尿系統市場成長機會，依區域
全球腎臟病學和泌尿系統市場新趨勢
戰略分析
- 新產品開發
- 擴大全球腎臟科和泌尿系統市場的產能
- 全球腎臟病學和泌尿系統市場的合併、收購和合資企業
- 認證和許可

第7章主要企業概況

Medtronic
Coloplast
Boston Scientific
ConvaTec
B. Braun
Hollister
Teleflex
Baxter
Fresenius Medical Care
Asahi Kasei

簡介目錄

Nephrology and Urology Trends and Forecast

The future of the global nephrology and urology market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global nephrology and urology market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of chronic diseases, the increasing number of dialysis patients, and the growing preference for minimally invasive (MI) devices.

Lucintel forecast that, within the product category, the percutaneous nephrostomy catheter is expected to witness the highest growth over the forecast period due to its significant use in treating problems from kidney transplants, decompressing nephric or perinephric fluid collection, and non-dilated obstructive therapies.
Within the end-use category, hospitals will remain the largest segment due to the increasing admission of renal disease patients, easy availability of advanced treatment devices, and the growing number of patients obtaining dialysis in medical facilities.
In terms of regions, North America is expected to witness the highest growth over the forecast period due to the growing number of kidney-affected patients, the presence of skilled physicians, and the availability of well-established healthcare facilities in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nephrology and Urology Market

Emerging trends in the nephrology and urology market have a bearing on future care given advances in technology as well as changing patient needs.

Integration of Artificial Intelligence: AI is progressively finding its way into diagnostic systems as well as treatment options available for nephrologists and urologists. AI algorithms are essential in improving diagnostics' accuracy, personalizing treatment plans, as well as enhancing predictive analytics thereby leading to improved patient outcomes.
Advancements in Minimally Invasive Surgery: The use of minimally invasive techniques such as laparoscopic surgery and robot-assisted surgery has been gaining popularity among surgeons. These approaches minimize complications, hasten recovery, and offer more accurate treatments thus benefiting patients.
Expansion of Telehealth Services: Telehealth technology is now being used more often by nephrologists and urologists allowing them to provide consultations remotely or monitor their patients over time. This trend makes it easier for all people regardless of their place of living to access healthcare services also simplifying the management of chronic conditions.
Focus on Personalized Medicine: Personalized medicine is catching on with treatments that fit individual genetic formulae and target specific health conditions. This model intends to maximize therapeutic effectiveness while minimizing side effects by customizing care using patient-specific data.
Development of Advanced Diagnostic Tools: Improved imaging techniques and biomarker-based tests are being witnessed in the field of diagnostics. These developments enable early detection and more accurate diagnosis of urology and kidney-related ailments.

These trends enhance diagnostic precision, treatment efficiency, and patient reachability; consequently reshaping the nephrology & urology market.

Recent Developments in the Nephrology and Urology Market

Advancements in technology and new treatment methods characterize the recent important developments in the nephrology and urology market.

Artificial Kidney Technologies: The artificial kidney technologies under development aim at improving dialysis efficiency as well as patients' comfort during therapy procedures. They mainly focus on designing wearable or implantable devices that mimic kidney functions better than ever before.
Robotic-Assisted Surgeries: Robotic-assisted surgery systems have been introduced into urological practice which has led to a revolution in urological operations. These assistive machines provide a higher level of precision and control, thus reducing complications while also speeding up recovery time.
Telehealth Integration: Telehealth's growth has improved the management of nephrology and urology at a distance. It is leading to greater patient involvement and increased availability through virtual consultations and remote monitoring tools.
Advanced Imaging Techniques: Modern imaging techniques, such as high-resolution MRI, and 3D ultrasound are improving diagnosis accuracy and treatment planning for renal and urological diseases.
Personalized Medicine Approaches: Personalized medicine has been taken up which facilitates individualized therapy based on patient profiles, leading to better outcomes in treatment while minimizing side effects.

These developments are driving innovation and improving the quality of care in nephrology and urology.

Strategic Growth Opportunities for Nephrology and Urology Market

Various applications among others have led to strategic growth opportunities emerging in this field.

Telemedicine Expansion: A significant avenue for expansion of telemedicine services is offered by increasing care access as well as enhancing patient management. To bridge service gaps reaching underserved populations; robust telehealth platforms should be developed.
Robotic Surgery Systems: Becoming an investor in robotic surgery systems brings about chances for growth as it provides state-of-the-art surgical solutions. In clinical settings, these systems promote precision and outcomes during urological surgeries.
Advances in artificial kidney technologies can lead to growth opportunities in the dialysis market. This, therefore, means that innovations aimed at making chronic kidney disease management more effective and convenient would be able to address this unmet need.
Personalized Treatment Solutions: Growth can result from personalized medicine approaches that utilize such patient data in the field of nephrology and urology. As a result, these developments are expected to improve therapeutic outcomes and satisfaction levels among patients.
Innovations in Diagnostic Tools: Early detection and monitoring of kidney and urological diseases may be improved through expanding the variety of diagnostic tools available. Consequently, advances in imaging as well as biomarker testing are poised to increase diagnostic accuracy.

These opportunities are shaping the Nephrology and Urology market by driving innovation and improving patient care.

Nephrology and Urology Market Driver and Challenges

The nephrology and urology market is influenced by various drivers, which are also major challenges that affect its growth as well as development.

The factors responsible for driving the nephrology and urology market include:

Technological Advancements: The use of innovative diagnostic tools, surgical techniques, and digital health solutions drives the increase of this market segment. These improvements lift efficiency as well as effectiveness throughout nephrology care especially when it comes to urologists.
Rising Incidence of Kidney and Urological Disorders: The increasing prevalence of renal and urogenital conditions is leading to the need for more sophisticated treatment options. This trend pushes forward the development and uptake of new technologies and therapies.
Growing Focus on Personalized Medicine: A shift toward personalized healthcare has increased successful treatment outcomes by adjusting medical regimens to suit individual patient profiles. Such a method is being recognized in nephrology as well as urology.
Expansion of Telehealth Services: The increasing growth in telehealth services is enhancing access to care and improving patient management. Nephrology and urology care are beginning to incorporate remote consultation and monitoring.
Increased Research and Development Investment: This funding promotes the advancement of nephrology as well as urology technologies through investment in research and development. It supports the creation of fresh therapeutic methods and diagnostic tools among other things.

Challenges in the nephrology and urology market are:

High Costs of Advanced Technologies: High prices for advanced technological devices can act as an obstacle to their adoption. Healthcare providers together with patients face a challenge in striking a balance between cost and accessibility.
Regulatory and Compliance Issues: Negotiating labyrinthine regulatory requirements while ensuring standards are met can be problematical. They affect issues like entry into the market or clearance for novel products.
Data Privacy Fears: It is a big task to ensure that patient data security and privacy are observed. To maintain trust, compliance with the rules of data protection and responding to patients' needs are essential.

The nephrology and urology market is being shaped by these driving forces and challenges by affecting innovation, purchase decisions as well as regulatory requirements.

List of Nephrology and Urology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nephrology and urology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nephrology and urology companies profiled in this report include-

Medtronic
Coloplast
Boston Scientific
ConvaTec
B. Braun
Hollister
Teleflex
Baxter
Fresenius Medical Care
Asahi Kasei

Nephrology and Urology by Segment

The study includes a forecast for the global nephrology and urology by product, application, end use industry, technology, and region

Nephrology and Urology Market by Product [Analysis by Value from 2018 to 2030]:

Ureteral Catheters
PCN Catheters
Urinary Stents
Stone Basket
Urology Guidewires
Renal Dilators

Nephrology and Urology Market by Application [Analysis by Value from 2018 to 2030]:

Urolithiasis
Urological Cancer & BPH
Bladder Disorders
Kidney Diseases
Others

Nephrology and Urology Market by End Use Industry [Analysis by Value from 2018 to 2030]:

Hospitals
Clinics
Ambulatory Surgical Centers
Others

Nephrology and Urology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Nephrology and Urology Market

The latest trends in the nephrology and urology market show innovative treatment technologies and a growing global attention to patient-centered care.

United States: The United States has witnessed significant milestones towards managing kidney diseases including the use of artificial kidneys and improved dialysis techniques. There is also an increasing trend for personalized medical care as well as telehealth solutions meant to enhance patients' outcomes in nephrology and urology.
China: Technological advancements in China have led to the rapid development of advanced diagnostic tools alongside minimal invasive surgical approaches. These include imaging innovations as well as robotic-assisted surgeries that are increasingly used to improve the efficiency of care processes and reduce recovery periods for patients with nephrological or urological conditions.
Germany: Germany is leading in digital health integration into nephrology and urology care. Most recently, there have been developments such as advanced telemedicine platforms and electronic health records for adequate management of chronic kidney diseases plus complex urological procedures support.
India: In India, however, there has been a focus on expanding access to nephrology/urology through affordable options & creation of specialized centers. Consequently, new technologies are being developed while existing ones are being refined so that they can be able to cope with the increasing number of renal disorders & urogenital abnormalities.
Japan: Japan is at the forefront of developing high-precision diagnostic tools and treatment technologies for nephrology and urology. Recent milestones include state-of-the-art imaging methods and robots with surgical precision that facilitate better results for patients.

Features of the Global Nephrology and Urology Market

Market Size Estimates: Nephrology and urology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nephrology and urology market size by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Nephrology and urology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the nephrology and urology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nephrology and urology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nephrology and urology market by product (ureteral catheters, PCN catheters, urinary stents, stone basket, urology guidewires, renal dilators, and others), application (urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Nephrology and Urology Market: Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Nephrology and Urology Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Nephrology and Urology Market by Product
- 3.3.1: Ureteral Catheters
- 3.3.2: PCN Catheters
- 3.3.3: Urinary Stents
- 3.3.4: Stone Basket
- 3.3.5: Urology Guidewires
- 3.3.6: Renal Dilators
- 3.3.7: Others
3.4: Global Nephrology and Urology Market by Application
- 3.4.1: Urolithiasis
- 3.4.2: Urological Cancer & BPH
- 3.4.3: Bladder Disorders
- 3.4.4: Kidney Diseases
- 3.4.5: Others
3.5: Global Nephrology and Urology Market by End Use Industry
- 3.5.1: Hospitals
- 3.5.2: Clinics
- 3.5.3: Ambulatory Surgical Centers
- 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Nephrology and Urology Market by Region
4.2: North American Nephrology and Urology Market
- 4.2.1: North American Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
- 4.2.2: North American Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
4.3: European Nephrology and Urology Market
- 4.3.1: European Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
- 4.3.2: European Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
4.4: APAC Nephrology and Urology Market
- 4.4.1: APAC Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
- 4.4.2: APAC Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
4.5: ROW Nephrology and Urology Market
- 4.5.1: ROW Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
- 4.5.2: ROW Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Nephrology and Urology Market by Product
- 6.1.2: Growth Opportunities for the Global Nephrology and Urology Market by Application
- 6.1.3: Growth Opportunities for the Global Nephrology and Urology Market by End Use Industry
- 6.1.4: Growth Opportunities for the Global Nephrology and Urology Market Region
6.2: Emerging Trends in the Global Nephrology and Urology Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Nephrology and Urology Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nephrology and Urology Market
- 6.3.4: Certification and Licensing